Barracuda Networks could be in line to exit the accountancy software producer, which had disclosed more than $31m in funding through 2015.

The UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

NeoGenomics has agreed to buy portfolio company Inivata, a liquid biopsy platform developer, a year after it invested $25m.

Framestore Ventures had backed the online comics platform developer's series B round, before the latter announced its closure last month.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

The Lennar-backed accommodation provider will take a Nasdaq listing having previously raised $530m, and was valued at $1.3bn as of June 2020.

The Tencent and SIG China-backed podcasting app developer, valued at $3.5bn three years ago, has filed for a US initial public offering.